Effect of dexamethasone on IL-2 and IL-3 production by mononuclear cells in neonates and adults.

Ward RM. The use of therapeutic drugs. In: Avery GB, Fletcher MA, MacDonald MG, eds. Neonatology. Pathophysiology and management of the newborn. Philadelphia: J.B Lippincott Company, 1994: 1291-2.

Harkavy KL, Scanlon JW, Chowdhry PK, Crylack U. Dexamethasone therapy for chronic lung disease in ventilatorand oxygen dependent infants: a controlled trial. J Pediatr 1989;115: 979-83.

Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 1989;320: 1505-10.

Gladstone IM, Ehrenkranz RA, Jacobs HC. Pulmonary function tests and fluid balance in neonates with chronic lung disease during dexamethasone treatment. Pediatrics 1989; 84: 1072-6.

Boumpas DT, Paliogianni F, Anastassiou ED, Balow JE. Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin Exp Rheumatol 1991; 9: 413-23.

Arya SK, Wong-Staal F, Gallo RC. Dexamethasone mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. J Immunol 1984;133: 273-6.

Bettens F, Kristensen F, Walker C, Schwulera U, Bonnard GD, de Weck AL. Lymphokine regulation of activated (GI) lymphocytes. II. Glucocorticoid and anti-Tacinduced inhibition of human T lymphocyte proliferation. Y Immunol 1984;132: 261-5.

Gillis S, Crabtree GR, Smith KA. Glucocorticoid-induced inhibition of T cell growth factor production: Effect on mitogen induced lymphocyte proliferation. J Immunol 1979;123: 1623-8.

Reed JC, Abidi AH, Alpers JD, Hoover RG, Robb RJ, Nowell PC. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. Y Immunol 1986;137: 150-4.

Kavelaars A, Zijlstra J, Bakker JM, Van-Rees EP, Visser GH, Zegers BJ, et al. Increased dexamethasone sensitivity of neonatal leukocytes: different mechanisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells. EurJY Immunol 1995;25: 1346-51.

Bessler H, Sirota L, Notti I, Milo T, Djaldetti M. Interleultn-2 receptor gene expression and interleukin-2 production by human preterm neonates' cells. Clin Exp Immunol 1993; 93: 479-83.

Palacios R, Karasuyama H, Rolink A. Lyl+ Pro-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo. Embo J 1987; 6: 3687-93.

Weinstein Y, Morishita K, Cleveland JL, Ihle JN. Interleukin 3 (IL-3) induces transcription from nonrearranged T cell receptor gamma loci in IL-3-dependent cell lines. J Exp Med 1989;169: 2059-71.

Serrate SA, Schulof RS, Leondaridis L, Goldstein AL, Sztein MB. Modulation of natural killer cell cytotoxic activity, lymphokine production and interleukin 2 receptor expression by thymic hormones. J Immunol 1987; 139: 2338-43.

SakakeenyMA, Greenberg JS. Granulopoiesis longevity in continuous bone marrow culture and factor dependent cell line generation: Significant variation among 28 inbred mouse strain ant outbid stocks. JNCI 1982; 68: 305-17.

Harris DT, Schumacher MJ, Locascio J, BesenconFH, Olson GB, Deluca D. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl AcadSci USA 1992;89:10006-10

Tucci A, Mouzaki A, James H, Bonnefoy JTY, Zubler RH. Are cord blood B cells functionally mature? Clin Exp Immunol 1991;84:389-94.

Taylor S, Bryson YJ. Impaired production of gamma interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol 1985;134:1493-7.

Hunt DWC, Huppertz HI, Jiang HJ, Petty RE. Studies of human cord blood dendritic cells: Evidence for functional immaturity. Blood 1994; 84: 4333-43.

Knudsen PJ, Dinarello CA, Strom TB. Glucocorticoids inhlbit transcriptional and post-tranariptional expression of interleukin 1 in U937 cells. JImmunol 1987; 139: 4129-34.

Lee SW, Tsuo PAP, Chan H, Thomas J, Petrie K, Euqui EM. Glucocorticoids selectively inhibit transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci USA 1988; 85: 1204-8.

Zanker B, Walz G, Wieder KJ, Storm TB. Evidence that glucocorticsteroids block expression of the human interleukin-6 gene by accessory cells. Transplantation 1990; 49:183-5.

Almawi WY, Lipman ML, Stevens AC, Zanker B, Hadro ET, Strom TB. Abrogation ofglucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma.jImmunol 1991;146: 3523-7.

Gessani S, McCandless S, Baglioni C. The glucocorticoid dexamethasone inhibits synthesis of interferon by decreasing the level of its mRNA. JBiol Chem 1988; 263: 7454-7.

Boumpas DT, Anastassiou ED, Older SA, Tsokos GC, Nelson DL, Balow JE. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. Clin Invest 1991; 87: 1739-47.

Fauci AS, Dale DC. The effect of in vivo hydrocortisone on subpopulation of human lymphocytes. Clin Invest 1974; 53: 240-6.

Kunica JE, Talle MA, Denhardt GH, Brown M, Price LA, Goldstein G. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administraion of dexamethasone. Cell Immunol 1993; 149: 39-49.